Plain-English translation of NCT06484374 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new way to treat large brain bleeds in an area called the basal ganglia using robot-assisted endoscopic surgery. The procedure uses artificial intelligence to plan the safest surgical path to remove the blood clot while protecting healthy brain tissue. Doctors hope this minimally invasive approach—using small incisions instead of large ones—will help patients recover better with fewer complications.
Large brain bleeds in the basal ganglia are very serious and often leave people with severe disability or death. Current surgical techniques can damage important brain structures. This trial exists to see whether robotic guidance and artificial intelligence can make surgery safer and help more patients recover their ability to walk, talk, and care for themselves.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will receive the robot-assisted endoscopic surgery to remove the blood clot from your brain. Your surgical team will use artificial intelligence to plan the safest route before surgery begins. After your procedure, you will have follow-up visits at 24 hours, 48 hours, 3 days, 14 days, 30 days, 90 days, and 6 months. At each visit, doctors will test your strength, balance, thinking, and ability to perform daily activities, and they may do imaging scans to monitor your recovery.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
China
Sponsor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Collaborators
Second Affiliated Hospital, School of Medicine, Zhejiang University, Affiliated Hospital of Nantong University
Enrollment target
~198 participants
Started
December 2025
Primary completion
June 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in February 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Chun-Hua Hang, PhD
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.